Genetic variants as predictive markers for ototoxicity and nephrotoxicity in patients (pts) with locally advanced head and neck cancer (LAHNC) treated with cisplatin-containing chemoradiotherapy ...
Barriers to symptom management in oncology. Background: 5-fluorouracil (5-FU) is widely used to treat solid tumors and is often administered via infusion pump at or near its maximum tolerated dose.
A dose-finding study was undertaken to determine the maximum-tolerated dose, and the recommended dose of docetaxel in combination with 12-h timed (22:00–10:00) flat infusion of 5-fluorouracil (5-FU) ...
The purpose of this assessment is to evaluate the clinical and cost effectiveness of the My5‑FU assay for the pharmacokinetic dose adjustment of continuous infusion 5‑fluorouracil (5‑FU) chemotherapy.
June 17, 2009 (Orlando, Florida) — There is now an antidote for clinicians to use in the event of an overdose of the commonly used chemotherapy 5-fluorouracil (5-FU), according to a poster ...
The My5‑FU assay (Saladax Biomedical Inc.), previously known as OnDose, is a CE‑marked in vitro diagnostic test designed to measure the levels of 5‑fluorouracil (5‑FU) chemotherapy in plasma samples.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback